Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer - A Review

被引：9

作者：

Serban, Dragos ^{[1
,2
]}

Costea, Daniel Ovidiu ^{[3
,4
]}

Zgura, Anca ^{[5
,6
]}

Tudosie, Mihail Silviu ^{[7
,8
]}

Dascalu, Ana Maria ^{[9
,10
]}

Gangura, Gabriel Andrei ^{[1
,11
]}

Smarandache, Catalin Gabriel ^{[1
,2
]}

Sabau, Alexandru Dan ^{[12
,13
]}

Tudor, Corneliu ^{[2
]}

Faur, Mihai ^{[12
,13
]}

Costea, Andreea Cristina ^{[14
]}

Stana, Daniela ^{[10
]}

Balasescu, Simona Andreea ^{[2
]}

Tribus, Laura Carina ^{[15
,16
]}

Tanasescu, Ciprian ^{[12
,13
]}

机构：

[1] Carol DavilaUniv Med & Pharm, Dept Gen Surg, Fac Med, Bucharest, Romania

[2] Emergency Univ Hosp, Dept Surg Emergency 4, Bucharest, Romania

[3] Ovidius Univ, Fac Med, Dept Clin Surg Disciplines 1, Constanta, Romania

[4] Emergency Cty Hosp, Surg Dept 1, Constanta, Romania

[5] Carol DavilaUniv Med & Pharm, Fac Med, Dept Oncol Radiol & Hematol, Bucharest, Romania

[6] Inst Oncol Prof Dr Alexandru Trestioreanu, Dept Oncol Radiotherapy, Bucharest, Romania

[7] Carol Davila Univ Med & Pharm, Fac Med, Dept Orthopedia & Intens Care, Bucharest, Romania

[8] Clin Emergency Hosp, ICU Toxicol 2, Bucharest, Romania

[9] Carol Davila Univ Med & Pharm, Fac Med, Dept ENT Ophthalmol, Bucharest, Romania

[10] Emergency Univ Hosp, Ophthalmol Dept, Bucharest, Romania

[11] Emergency Univ Hosp, Dept Surg 2, Bucharest, Romania

[12] Lucian Blaga Univ, Fac Med, Surg Clin Dept, Sibiu, Romania

[13] Sibiu Cty Emergency Clin Hosp, Dept Surg, Sibiu, Romania

[14] Diaverum Clin, Nephrol & Dialysis Dept, Constanta, Romania

[15] Carol Davila Univ Med & Pharm, Dept Internal Med Gastroenterol, Fac Med, Bucharest, Romania

[16] Emergency Univ Hosp Bucharest, Gastroenterol Dept, Bucharest, Romania

来源：

IN VIVO | 2022年 / 36卷 / 01期

关键词：

Breast cancer; endocrine therapy; aromatase inhibitors; ocular side-effects; dry eye; anastrozole; review; DRY-EYE SYNDROME; POSTMENOPAUSAL WOMEN; ADJUVANT TREATMENT; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL; SURFACE DISEASE; ANASTROZOLE; ESTROGEN; LETROZOLE; EXEMESTANE;

D O I：

10.21873/invivo.12674

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

in patients with breast cancer. Materials and Methods: A comprehensive search was performed on PubMed, Web of Science and Google scholar. Results: After duplication removal, 14 clinical studies and 5 case reports, published between 2008 and 2021, were identified. Most frequently, AI treatment resulted in minor to moderate dry eye symptoms. "De novo" onset of Sjogren syndrome during AI therapy was also reported. Retinal and optic nerve side effects varied from mild, subclinical anatomic and functional impairment to severe decreased vision, secondary to hemi-central retinal artery occlusion, bilateral optic neuritis or uveitis with bilateral macular edema. Conclusion: Visual disturbances encountered during AI treatment may be underestimated. Ophthalmic screening is important for early detection and appropriate treatment.

引用

页码：40 / 48

页数：9

共 50 条

[21] Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors
van Ommen-Nijhof, Annemiek
Jacobse, Judy N.
Steggink, Lars C.
Lefrandt, Joop D.
Gietema, Jourik A.
van Leeuwen, Flora E.
Schaapveld, Michael
Sonke, Gabe S.
BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (03) : 591 - 602
[22] Endocrine therapy after aromatase inhibitor therapy in breast cancer
Verma, Mohit K.
Miki, Yasuhiro
Sasano, Hironobu
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (03) : 309 - 312
[23] Aromatase inhibitors: past, present and future in breast cancer therapy
Dutta, Udayan
Pant, Kartikeya
MEDICAL ONCOLOGY, 2008, 25 (02) : 113 - 124
[24] Neoadjuvant endocrine therapy for resectable breast cancer: A systematic review and meta-analysis
Leal, Frederico
Liutti, Vitor Teixeira
Antunes dos Santos, Vivian Castro
Novis de Figueiredo, Maximiliano Augusto
Macedo, Ligia Traldi
Rinck Junior, Jose Augusto
Sasse, Andre Deeke
BREAST, 2015, 24 (04) : 406 - 412
[25] Personalizing aromatase inhibitor therapy in patients with breast cancer
Hamadeh, Issam S.
Patel, Jai N.
Rusin, Stephanie
Tan, Antoinette R.
CANCER TREATMENT REVIEWS, 2018, 70 : 47 - 55
[26] Aromatase inhibitor therapy and hair loss among breast cancer survivors
Gallicchio, Lisa
Calhoun, Carla
Helzlsouer, Kathy J.
BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (02) : 435 - 443
[27] Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
Gnant, Michael
Fitzal, Florian
Rinnerthaler, Gabriel
Steger, Guenther G.
Greil-Ressler, Sigrun
Balic, Marija
Heck, Dietmar
Jakesz, Raimund
Thaler, Josef
Egle, Daniel
Manfreda, Diether
Bjelic-Radisic, Vesna
Wieder, Ursula
Singer, Christian F.
Melbinger-Zeinitzer, Elisabeth
Haslbauer, Ferdinand
Sevelda, Paul
Trapl, Harald
Wette, Viktor
Wimmer, Kerstin
Gampenrieder, Simon P.
Bartsch, Rupert
Kacerovsky-Strobl, Stephanie
Suppan, Christoph
Brunner, Christine
Deutschmann, Christine
Soelkner, Lidija
Fesl, Christian
Greil, Richard
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (05) : 395 - 405
[28] Aromatase inhibitors: past, present and future in breast cancer therapy
Udayan Dutta
Kartikeya Pant
Medical Oncology, 2008, 25 : 113 - 124
[29] Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer
van de Velde, C. J. H.
Verma, S.
van Nes, J. G. H.
Masterman, C.
Pritchard, K. I.
CANCER TREATMENT REVIEWS, 2010, 36 (01) : 54 - 62
[30] Use of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer at German Breast Cancer Centers and University Hospitals - Results of an Enquiry (Adjuvant Endocrine Therapy Enquiry)
Kolben, Thomas
Engelmann, Susanne
Maurer, Susanne
Kolben, Martin
BREAST CARE, 2012, 7 (01) : 39 - 44

← 1 2 3 4 5 →